hepsulfam has been researched along with Leukopenia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Geller, RB; Grochow, LB; Janisch, L; Larson, RA; Milton, J; Ratain, MJ | 1 |
Donehower, RC; Ettinger, DS; Forastiere, AA; Grochow, LB; Hendricks, CB; Lubejko, B; McGuire, WP; Rowinsky, EK; Sartorius, S | 1 |
Brown, TD; Havlin, KA; Koeller, JM; Kuhn, JG; Marshall, MV; Ravdin, PM; Rodriguez, G; Von Hoff, DD | 1 |
3 trial(s) available for hepsulfam and Leukopenia
Article | Year |
---|---|
Encephalopathy is the dose-limiting toxicity of intravenous hepsulfam: results of a phase I trial in patients with advanced hematological malignancies.
Topics: Adult; Aged; Antineoplastic Agents; Blast Crisis; Brain Diseases; Coma; Dose-Response Relationship, Drug; Electroencephalography; Female; Humans; Infusions, Intravenous; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Leukopenia; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sulfonic Acids; Thrombocytopenia | 1995 |
Phase I and pharmacokinetic study of hepsulfam (NSC 329680).
Topics: Adult; Antineoplastic Agents; Drug Evaluation; Female; Humans; Leukopenia; Male; Metabolic Clearance Rate; Neoplasms; Neutropenia; Sulfonic Acids; Thrombocytopenia | 1991 |
A phase I clinical and pharmacokinetic trial of hepsulfam.
Topics: Aged; Antineoplastic Agents; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukopenia; Male; Middle Aged; Neoplasms; Sulfonic Acids; Thrombocytopenia | 1991 |